NVS logo

Novartis AG (NVS) Working capital

annual working capital:

$1.01B-$3.08B(-75.26%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVS annual working capital is $1.01 billion, with the most recent change of -$3.08 billion (-75.26%) on December 31, 2024.
  • During the last 3 years, NVS annual working capital has fallen by -$14.50 billion (-93.48%).
  • NVS annual working capital is now -93.48% below its all-time high of $15.51 billion, reached on December 31, 2021.

Performance

NVS Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSbalance sheet metrics

quarterly working capital:

-$6.51B-$7.52B(-743.38%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVS quarterly working capital is -$6.51 billion, with the most recent change of -$7.52 billion (-743.38%) on March 31, 2025.
  • Over the past year, NVS quarterly working capital has dropped by -$3.67 billion (-129.18%).
  • NVS quarterly working capital is now -131.25% below its all-time high of $20.84 billion, reached on June 30, 2010.

Performance

NVS quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVSbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

NVS Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-75.3%-129.2%
3 y3 years-93.5%-187.6%
5 y5 years-18.4%+20.6%

NVS Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-93.5%at low-162.0%at low
5 y5-year-93.5%+129.9%-142.0%+20.6%
alltimeall time-93.5%+129.9%-131.3%+20.6%

NVS Working capital History

DateAnnualQuarterly
Mar 2025
-
-$6.51B(-743.4%)
Dec 2024
$1.01B(-75.3%)
$1.01B(-67.7%)
Sep 2024
-
$3.13B(-263.2%)
Jun 2024
-
-$1.92B(-32.5%)
Mar 2024
-
-$2.84B(-169.4%)
Dec 2023
$4.09B(-50.4%)
$4.09B(-249.7%)
Sep 2023
-
-$2.73B(-272.5%)
Jun 2023
-
$1.58B(+1.2%)
Mar 2023
-
$1.56B(-81.0%)
Dec 2022
$8.25B(-46.8%)
$8.25B(-6.1%)
Sep 2022
-
$8.79B(-16.2%)
Jun 2022
-
$10.50B(+41.3%)
Mar 2022
-
$7.43B(-52.1%)
Dec 2021
$15.51B(-558.1%)
$15.51B(-527.6%)
Sep 2021
-
-$3.63B(-37.7%)
Jun 2021
-
-$5.83B(-26.8%)
Mar 2021
-
-$7.96B(+135.1%)
Dec 2020
-$3.39B(-373.1%)
-$3.39B(+18.2%)
Sep 2020
-
-$2.87B(-47.9%)
Jun 2020
-
-$5.50B(-32.9%)
Mar 2020
-
-$8.20B(-761.0%)
Dec 2019
$1.24B(-79.2%)
$1.24B(-180.3%)
Sep 2019
-
-$1.54B(-13.7%)
Jun 2019
-
-$1.79B(-51.3%)
Mar 2019
-
-$3.68B(-161.8%)
Dec 2018
$5.96B(+24.0%)
$5.96B(+2.9%)
Sep 2018
-
$5.79B(+40.4%)
Jun 2018
-
$4.12B(-14.6%)
Mar 2018
-
$4.83B(+0.5%)
Dec 2017
$4.80B(+76.5%)
$4.80B(+130.2%)
Sep 2017
-
$2.09B(+432.4%)
Jun 2017
-
$392.00M(-169.5%)
Mar 2017
-
-$564.00M(-120.7%)
Dec 2016
$2.72B(-415.4%)
$2.72B(+112.8%)
Sep 2016
-
$1.28B(-150.2%)
Jun 2016
-
-$2.55B(-47.2%)
Mar 2016
-
-$4.82B(+459.0%)
Dec 2015
-$863.00M(-108.2%)
-$863.00M(-79.0%)
Sep 2015
-
-$4.11B(-11.4%)
Jun 2015
-
-$4.64B(+38.9%)
Mar 2015
-
-$3.34B(-131.6%)
Dec 2014
$10.59B(+153.7%)
$10.59B(+4.1%)
Sep 2014
-
$10.17B(+37.1%)
Jun 2014
-
$7.42B(+50.5%)
Mar 2014
-
$4.93B(+18.1%)
Dec 2013
$4.17B(+5.6%)
$4.17B(+41.1%)
Sep 2013
-
$2.96B(+20.4%)
Jun 2013
-
$2.46B(+476.8%)
Mar 2013
-
$426.00M(-89.2%)
DateAnnualQuarterly
Dec 2012
$3.95B(+322.3%)
$3.95B(-7.8%)
Sep 2012
-
$4.29B(+256.8%)
Jun 2012
-
$1.20B(-176.6%)
Mar 2012
-
-$1.57B(-267.6%)
Dec 2011
$936.00M(-53.8%)
$936.00M(-450.6%)
Sep 2011
-
-$267.00M(-90.8%)
Jun 2011
-
-$2.91B(-6.7%)
Mar 2011
-
-$3.12B(-253.7%)
Dec 2010
$2.03B(-85.7%)
$2.03B(+3335.6%)
Sep 2010
-
$59.00M(-99.7%)
Jun 2010
-
$20.84B(+13.4%)
Mar 2010
-
$18.37B(+29.2%)
Dec 2009
$14.22B(+224.9%)
$14.22B(+13.4%)
Sep 2009
-
$12.54B(+6.1%)
Jun 2009
-
$11.81B(+57.7%)
Mar 2009
-
$7.49B(+71.2%)
Dec 2008
$4.38B(-59.4%)
$4.38B(+30.9%)
Sep 2008
-
$3.34B(-73.0%)
Jun 2008
-
$12.40B(+34.4%)
Mar 2008
-
$9.23B(-14.4%)
Dec 2007
$10.79B(+108.7%)
$10.79B(-3.5%)
Sep 2007
-
$11.18B(+140.1%)
Jun 2007
-
$4.66B(+23.0%)
Mar 2007
-
$3.79B(-26.8%)
Dec 2006
$5.17B(-15.5%)
$5.17B(+11.0%)
Sep 2006
-
$4.66B(+53.3%)
Jun 2006
-
$3.04B(-52.0%)
Mar 2006
-
$6.33B(+3.4%)
Dec 2005
$6.12B(-49.3%)
$6.12B(+1.6%)
Sep 2005
-
$6.02B(-19.4%)
Jun 2005
-
$7.47B(-31.7%)
Mar 2005
-
$10.94B(-9.4%)
Dec 2004
$12.07B(-6.8%)
$12.07B(-4.0%)
Sep 2004
-
$12.57B(-0.5%)
Jun 2004
-
$12.64B(+7.2%)
Mar 2004
-
$11.79B(-9.0%)
Dec 2003
$12.95B(+3.3%)
$12.95B(+6.4%)
Sep 2003
-
$12.17B(+17.7%)
Jun 2003
-
$10.34B(-16.2%)
Mar 2003
-
$12.34B(-1.6%)
Dec 2002
$12.54B(+4.1%)
$12.54B(+27.4%)
Sep 2002
-
$9.84B(-22.1%)
Jun 2002
-
$12.64B(+4.9%)
Dec 2001
$12.05B(-8.7%)
$12.05B(+61.0%)
Jun 2001
-
$7.49B(-43.3%)
Dec 2000
$13.20B(+21.7%)
$13.20B(-7.6%)
Jun 2000
-
$14.29B
Dec 1999
$10.84B(-0.3%)
-
Dec 1998
$10.87B
-

FAQ

  • What is Novartis AG annual working capital?
  • What is the all time high annual working capital for Novartis AG?
  • What is Novartis AG annual working capital year-on-year change?
  • What is Novartis AG quarterly working capital?
  • What is the all time high quarterly working capital for Novartis AG?
  • What is Novartis AG quarterly working capital year-on-year change?

What is Novartis AG annual working capital?

The current annual working capital of NVS is $1.01B

What is the all time high annual working capital for Novartis AG?

Novartis AG all-time high annual working capital is $15.51B

What is Novartis AG annual working capital year-on-year change?

Over the past year, NVS annual working capital has changed by -$3.08B (-75.26%)

What is Novartis AG quarterly working capital?

The current quarterly working capital of NVS is -$6.51B

What is the all time high quarterly working capital for Novartis AG?

Novartis AG all-time high quarterly working capital is $20.84B

What is Novartis AG quarterly working capital year-on-year change?

Over the past year, NVS quarterly working capital has changed by -$3.67B (-129.18%)
On this page